AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 19(1), 1970, pp. 138-145
Copyright © 1970 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gajdusek, D. C.
Right arrow Articles by Brown, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gajdusek, D. C.
Right arrow Articles by Brown, P.

IV. Kuru: Pathogenesis and Characterization of Virus

D. Carleton Gajdusek, Paul Brown, Editors, Clarence J. Gibbs, Jr., Paul Brown, Editors, D. Carleton Gajdusek AND Paul Brown, Editors
National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20014

Kuru, a subacute, progressive degenerative disease of the central nervous system of man, has an infectious etiology and is experimentally transmissible to other primates. Thus far, 91 chimpanzees have been inoculated with specimens from 37 human kuru victims (44 animals) or from other chimpanzees and spider monkeys with experimental kuru (47 animals). Among these, the disease has already developed in 35 chimpanzees: in 15 on primary passage, in 10 on second passage, in eight on third passage, and in two on fourth passage. Brain tissue from 11 human victims has induced disease in 15 animals, after incubation periods ranging from 14 to 38 months. The kuru virus remains viable in human brain tissue stored at -70°C for more than 5 years. The virus is serially transmissible in chimpanzees by intracerebral and peripheral routes of inoculation and can be recovered from visceral tissues as well as brain tissues. Serial passage is associated with a reduced incubation period, and the virus is detectable in the brains of chimpanzees before the onset of clinical disease. The virus has also been transmitted from a chimpanzee to spider monkeys after an incubation period of 2 years. In suspensions of both human and chimpanzee brain tissue the virus passes through a 220 µm millipore filter. By the intracerebral route chimpanzee brain tissue has an infectivity titer equal to or greater than 10-7.5 per ml. The virus is not completely inactivated after exposure to a temperature of 85°C for 30 minutes, and it remains viable after lyophylization and storage at a temperature of -20°C. Virus infectiousness for chimpanzees by the intracerebral route of inoculation was not neutralized at a dilution of 10-3 when mixed with pooled, undiluted serum from human kuru victims or pooled, undiluted serum from neighboring normal Anga (Kukukuku) people of the Eastern Highlands of New Guinea. Experiments are under way to investigate the possibility of infection after oral inoculation of chimpanzees with human and chimpanzee kuru-infected tissues.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Society of Tropical Medicine and Hygiene.